The MarketWatch News Department was not involved in the creation of this content.
Sep 22, 2020 (AmericaNewsHour) —
The global Viral Inactivationmarket was valued at USD 320.34million in 2016 and is projected to reach USD 903.43millionby 2025, growing at a CAGR of 12.21% from 2017 to 2025.
This method is one in which the viruses may remain in the final product, but in a non-infective form. The method is highly applicable in modern vaccine development techniques and treatment of other viral diseases involving their study and research. The market is thus expected to grow at a high CAGR.
The Final Report will cover the impact analysis of COVID-19 on this industry:
Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10059469
1. Market Drivers
1.1 Rapid Growth in R&D sector and discoveries
1.2 Increasing fund availability for Biopharmaceutical sector
1.3 Increasing demand for Biopharmaceuticals
1.4 Increasing support from public